Literature DB >> 8220086

Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia.

N Muñoz1, F X Bosch, S de Sanjosé, A Vergara, A del Moral, M T Muñoz, L Tafur, M Gili, I Izarzugaza, P Viladiu.   

Abstract

A case-control study of 525 histologically confirmed cases of cervical intraepithelial neoplasia grade III and 512 controls was done in Spain and Colombia to assess the role of various risk factors taking into account the effect of human papillomavirus (HPV). The presence of HPV DNA, assessed by a polymerase chain reaction-based method, was the strongest risk factor identified. In Spain the adjusted odds ratio (OR) and 95% confidence interval (CI) (numbers in parentheses) were 56.9 (24.8-130.6) and, in Colombia, were 15.5 (8.2-29.4). In addition to HPV, the multivariate analysis revealed independent effects of early age at first intercourse (in Spain ORa, 4.3; 95% CI, 2.0-9.3 for ages < 17 versus 20+ years and in Colombia ORa, 9.0; 95% CI, 2.6-30.9 for ages < 14 versus 20+ years), and antibodies to Chlamydia trachomatis (in Spain ORa, 2.3; 95% CI, 1.1-4.5; and in Colombia ORa, 1.7; 95% CI, 1.1-2.7). High parity showed a significant effect only in Colombia (ORa, 2.0; 95% CI, 1.0-5.0 for > or = 6 versus 1) while number of partners of the woman and specially of her husband showed a strong effect in Spain only (ORa, 6.9; 95% CI, 3.1-15.3 for partners of the husband > or = 21 versus 1-5). Smoking and use of oral contraceptives did not show significant or consistent associations. Among HPV-DNA positive women early age at first intercourse and high parity increased the risk of cervical intraepithelial neoplasia III but the effect was statistically significant only for the former.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220086

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

Review 1.  Screening, Surveillance, and Treatment of Anal Intraepithelial Neoplasia.

Authors:  Kevin C Long; Raman Menon; Amir Bastawrous; Richard Billingham
Journal:  Clin Colon Rectal Surg       Date:  2016-03

2.  The role of healthcare providers in HPV vaccination programs - A meeting report.

Authors:  Alex Vorsters; Paolo Bonanni; Helena C Maltezou; Joanne Yarwood; Noel T Brewer; F Xavier Bosch; Sharon Hanley; Ross Cameron; Eduardo L Franco; Marc Arbyn; Nubia Muñoz; Mira Kojouharova; Jade Pattyn; Marc Baay; Emilie Karafillakis; Pierre Van Damme
Journal:  Papillomavirus Res       Date:  2019-08-30

3.  IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.

Authors:  Hugo Sousa; Alexandra M Santos; Raquel Catarino; Daniela Pinto; José Moutinho; Paulo Canedo; José Carlos Machado; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 4.  Oral contraceptives and cancer. A review of the evidence.

Authors:  C La Vecchia; A Tavani; S Franceschi; F Parazzini
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

Review 5.  Nutrition and cervical neoplasia.

Authors:  N Potischman; L A Brinton
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

6.  Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study.

Authors:  Cristiana Banila; Attila T Lorincz; Dorota Scibior-Bentkowska; Gary M Clifford; Birhanu Kumbi; Dereje Beyene; Cosette M Wheeler; Kate Cuschieri; Jack Cuzick; Belinda Nedjai
Journal:  Int J Cancer       Date:  2021-10-11       Impact factor: 7.396

7.  Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G.

Authors:  S Oliveira; J Ribeiro; H Sousa; D Pinto; I Baldaque; R Medeiros
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

8.  Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.

Authors:  Luisa Galati; Jean-Damien Combes; Florence Le Calvez-Kelm; Sandrine McKay-Chopin; Nathalie Forey; Mathis Ratel; James McKay; Tim Waterboer; Lea Schroeder; Gary Clifford; Massimo Tommasino; Tarik Gheit
Journal:  Microbiol Spectr       Date:  2022-02-28

9.  Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries.

Authors:  K S Louie; S de Sanjose; M Diaz; X Castellsagué; R Herrero; C J Meijer; K Shah; S Franceschi; N Muñoz; F X Bosch
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

10.  Smoking enhances risk for new external genital warts in men.

Authors:  Dorothy J Wiley; David Elashoff; Emmanuel V Masongsong; Diane M Harper; Karen H Gylys; Michael J Silverberg; Robert L Cook; Lisette M Johnson-Hill
Journal:  Int J Environ Res Public Health       Date:  2009-03-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.